Home » Newsletters » BioWorld Asia

BioWorld Asia

Oct. 6, 1999

View Archived Issues

OECD's Role, Stature In GMO Issues To Be More Prominent

GPC Enters Broad $20M Deal With Hoechst In Osteoarthritis

Europe's Largest Biotech Fair Attracts 10,000 To Hanover

Neurosearch Plans To Spin Out Work In Cell And Gene Therapy

Quadrant Stops Development Of Oral Cyclosporin Product

Heart Drug Show Promise In Degenerative Eye Disease

MDS Enters Emerging Field, Forms Proteomics Company

Antisoma Seeks Partner For Theragyn While It Has Money

AnalytiCon AG: Fast Lane to Drugs From Natural Compounds

French Researchers Identify Cavernous Angiomas Gene

XTL's Fully Human Antibody Enters Phase I Study In HBV

EU Requests Labeling For Genetically Modified Feeds

Cerep, RPR Sign New Deal, Amend Existing Collaboration

Australian Tax Changes Will Boost Biotech Investments

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...